Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Assessing COVID-19 Vulnerability Among HIV-positive Men Who Have Sex With Men in Korea: The Role of Vaccination and Sexual Behaviors

  • Minsoo Jung (Department of Health Science, Dongduk Women's University College of Natural Science)
  • Received : 2024.04.11
  • Accepted : 2024.06.12
  • Published : 2024.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Comorbidities increase susceptibility to severe coronavirus disease 2019 (COVID-19) infections, but limited information has been published regarding human immunodeficiency virus (HIV) and COVID-19 co-infections. This study explored the relationships among socioeconomic characteristics, sexual behaviors, and COVID-19 infection rates among Korean men who have sex with men (MSM) who are also living with HIV. Methods: Data were collected through a web survey aimed at members of the largest gay portal site in Korea, supported by the National Research Foundation of Korea (n=1005). The primary independent variables included COVID-19-related vaccinations and sexual behaviors. The dependent variable was the incidence of COVID-19 infection among respondents during the pandemic. For statistical analysis, hierarchical multiple logistic regression was performed, controlling for potential confounding variables. Results: Model I indicated that older MSM were less likely to contract COVID-19 (adjusted odds ratio [aOR], 0.98; 95% confidence interval [CI], 0.96 to 0.99). Model II demonstrated that HIV-positive MSM were nearly twice as likely to be infected with COVID-19 compared to their HIV-negative counterparts (aOR, 1.97; 95% CI, 1.14 to 3.41). Furthermore, even after accounting for COVID-19 vaccination status in model III, HIV-positive MSM continued to show a higher risk of infection (aOR, 1.93; 95% CI, 1.12 to 3.35). Conclusions: The findings of this study indicate that HIV-positive MSM are at an increased risk of contracting COVID-19, even when their vaccination status is considered. Therefore, it is essential to prioritize the prevention of COVID-19 infections in HIV-positive individuals by administering appropriate antiretroviral therapy and ensuring adherence to public health guidelines.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2022R1F1A1062998).

References

  1. Chen S, Prettner K, Kuhn M, Bloom DE. The economic burden of COVID-19 in the United States: estimates and projections under an infection-based herd immunity approach. J Econ Ageing 2021;20:100328. https://doi.org/10.1016/j.jeoa.2021.100328
  2. Pei S, Yamana TK, Kandula S, Galanti M, Shaman J. Burden and characteristics of COVID-19 in the United States during 2020. Nature 2021;598(7880):338-341. https://doi.org/10.1038/s41586-021-03914-4
  3. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 2020;78:185-193. https://doi.org/10.1016/j.ijsu.2020.04.018
  4. World Health Organization. Coronavirus (COVID-19) dashboard [cited 2023 Feb 22]. Available from: https://data.who.int/dashboards/covid19/cases?n=c
  5. Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med 2021;385(15):1355-1371. https://doi.org/10.1056/NEJMoa2110362
  6. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020;383(27):2603-2615. https://doi.org/10.1056/NEJMoa2034577
  7. Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021;385(7):585-594. https://doi.org/10.1056/NEJMoa2108891
  8. Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, et al. Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS One 2021;16(3):e0248281. https://doi.org/10.1371/journal.pone.0248281
  9. Cho SI, Yoon S, Lee HJ. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database. Sci Rep 2021;11(1):6375. https://doi.org/10.1038/s41598-021-85813-2
  10. Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep 2021;11(1):6283. https://doi.org/10.1038/s41598-021-85359-3
  11. Liang M, Luo N, Chen M, Chen C, Singh S, Singh S, et al. Prevalence and mortality due to COVID-19 in HIV co-infected population: a systematic review and meta-analysis. Infect Dis Ther 2021;10(3):1267-1285. https://doi.org/10.1007/s40121-021-00447-1
  12. SeyedAlinaghi S, Karimi A, MohsseniPour M, Barzegary A, Mirghaderi SP, Fakhfouri A, et al. The clinical outcomes of COVID19 in HIV-positive patients: a systematic review of current evidence. Immun Inflamm Dis 2021;9(4):1160-1185. https://doi.org/10.1002/iid3.497
  13. Mellor MM, Bast AC, Jones NR, Roberts NW, Ordonez-Mena JM, Reith AJ, et al. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS 2021;35(4):F1-F10. https://doi.org/10.1097/QAD.0000000000002836
  14. Ambrosioni J, Blanco JL, Reyes-Uruena JM, Davies MA, Sued O, Marcos MA, et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV 2021;8(5):e294-e305. https://doi.org/10.1016/S2352-3018(21)00070-9
  15. Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, et al. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature 2019;570(7760):189-193. https://doi.org/10.1038/s41586-019-1200-9
  16. Richman DD. Normal physiology and HIV pathophysiology of human T-cell dynamics. J Clin Invest 2000;105(5):565-566. https://doi.org/10.1172/JCI9478
  17. Kouanfack OS, Kouanfack C, Billong SC, Cumber SN, Nkfusai CN, Bede F, et al. Epidemiology of opportunistic infections in HIV infected patients on treatment in accredited HIV treatment centers in Cameroon. Int J MCH AIDS 2019;8(2):163-172. https://doi.org/10.21106/ijma.302
  18. Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med 2020;382(21):2049-2055. https://doi.org/10.1056/NEJMsb2005114
  19. Kwon RH, Kim SH, Jung M. Behavioral predictors associated with HIV screening needs in gay Korean men during the COVID-19 pandemic. PLoS One 2023;18(6):e0287061. https://doi.org/10.1371/journal.pone.0287061
  20. Family Health International. Behavioral surveillance surveys: guidelines for repeated behavioral surveys in populations at risk of HIV; 2021 [cited 2023 Feb 22]. Available from: https://www.aidsdatahub.org/sites/default/files/resource/bss-guidelines-repeated-behavioral-surveys-populations-risk-hiv.pdf
  21. Algarin AB, Varas-Rodriguez E, Valdivia C, Fennie KP, Larkey L, Hu N, et al. Symptoms, stress, and HIV-related care among older people living with HIV during the COVID-19 pandemic, Miami, Florida. AIDS Behav 2020;24(8):2236-2238. https://doi.org/10.1007/s10461-020-02869-3
  22. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The burden of COVID-19 in people living with HIV: a syndemic perspective. AIDS Behav 2020;24(8):2244-2249. https://doi.org/10.1007/s10461-020-02871-9
  23. Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review. HIV Med 2020;21(9):567-577. https://doi.org/10.1111/hiv.12911
  24. Vizcarra P, Perez-Elias MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 2020;7(8):e554-e564. https://doi.org/10.1016/S2352-3018(20)30164-8
  25. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019;393(10189):2428-2438. https://doi.org/10.1016/S0140-6736(19)30418-0
  26. Tomar A, Spadine MN, Graves-Boswell T, Wigfall LT. COVID-19 among LGBTQ+ individuals living with HIV/AIDS: psycho-social challenges and care options. AIMS Public Health 2021;8(2):303-308. https://doi.org/10.3934/publichealth.2021023
  27. Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, et al. Clinical features and outcomes of patients with human immunodeficiency virus with COVID-19. Clin Infect Dis 2020;71(16):2276-2278. https://doi.org/10.1093/cid/ciaa579
  28. Ridgway JP, Farley B, Benoit JL, Frohne C, Hazra A, Pettit N, et al. A case series of five people living with HIV hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDS 2020;34(8):331-335. https://doi.org/10.1089/apc.2020.0103
  29. Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AA, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin Infect Dis 2021;73(7):e1964-e1972. https://doi.org/10.1093/cid/ciaa1339
  30. Sohn A, Cho B. Knowledge, attitudes, and sexual behaviors in HIV/AIDS and predictors affecting condom use among men who have sex with men in South Korea. Osong Public Health Res Perspect 2012;3(3):156-164. https://doi.org/10.1016/j.phrp.2012.07.001
  31. Kwon RH, Jung M. Associations between conventional healthy behaviors and social distancing during the COVID-19 pandemic: evidence from the 2020 Community Health Survey in Korea. J Prev Med Public Health 2022;55(6):568-577. https://doi.org/10.3961/jpmph.22.351
  32. Jung M. Behavioral predictors associated with COVID-19 vaccination and infection among men who have sex with men in Korea. J Prev Med Public Health 2024;57(1):28-36. https://doi.org/10.3961/jpmph.23.381